Security · CUSIP 02043QAB3
ALNYLAM PHARMACEUTICALS INC
NOTE 1.000% 9/1 · institutional ownership from 13F filings
13F holders
5
Shares held
594.8K
Value held
$715.3K
New / sold out
0 / 4
Added / reduced
0 / 1
net -13.9M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| SEI INVESTMENTS CO | 251,000 | $301.8K | 0.00% |
| Bank of New York Mellon Corp | 215,000 | $258.7K | 0.00% |
| OPPENHEIMER ASSET MANAGEMENT INC. | 80,000 | $96.2K | 0.00% |
| BOUSSARD & GAVAUDAN GESTION SAS | 24,763 | $29.8K | 0.00% |
| STEPHENS INC /AR/ | 24,000 | $28.9K | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | Sold out | -9,750,000 | -100.0% |
| SSI INVESTMENT MANAGEMENT LLC | Sold out | -4,098,000 | -100.0% |
| MML INVESTORS SERVICES, LLC | Sold out | -10,000 | -100.0% |
| LOOMIS SAYLES & CO L P | Sold out | -4,860 | -100.0% |
| OPPENHEIMER ASSET MANAGEMENT INC. | Reduced | -1,000 | -1.2% |